Prothena

$12.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.19 (-8.97%) Today

$0.00 (0.00%) As of 1:07 PM UTC after-hours

Why Robinhood?

You can buy or sell Prothena and other stocks, options, and ETFs commission-free!

About PRTA

Prothena Corporation plc Ordinary Shares, also called Prothena, is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland. The listed name for PRTA is Prothena Corporation plc Ordinary Shares.

CEO

Gene G. Kinney

Employees

Headquarters

Dun Laoghaire, Dublin

Founded

1969

Market Cap

500.38M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

190.94K

High Today

$13.50

Low Today

$11.88

Open Price

$12.97

Volume

338.36K

52 Week High

$14.72

52 Week Low

$7.10

Collections

Analyst Ratings

43%

of 7 ratings

Buy

43%

Hold

43%

Sell

14%

PRTA Earnings

-$0.77

-$0.51

-$0.26

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 10, After Hours